Senior insider sale
President and CEO at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$2.24M
175.43K shares
What this filing means
CAMPBELL BRADLEY L plans to sell 175.43K shares of AMICUS THERAPEUTICS, INC. valued at approximately $2.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001950047-26-002012
DirectorOfficer· President and CEO
Since Mar 2026
175.43K
Shares to sell
$2.24M
Approx. market value
22.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted and Performance Stock Units
N/A
1/3/2021
22.50KTotal acquired22.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2021 | Restricted and Performance Stock Units N/A | 22.50K | — |
| Total | 22.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
75K
Market value
$1.07M
1/20/2026
—Completed
Units to sell
7.50K
Market value
$82.5K
12/15/2025
—Completed
Units to sell
70.43K
Market value
$763.5K
12/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.50K
Market value
$323.3K
3/2/2026
Total
Units
175.43K
Value
$2.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 75K | $1.07M | — | Completed |
12/15/2025 | 7.50K | $82.5K | — | Completed |
12/15/2025 | 70.43K | $763.5K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 22.50K | $323.3K | NASDAQ | Planned |
| Total | 175.43K | $2.24M | ||